The proposed "Therapeutic Psilocybin Act" in West Virginia aims to create a regulated framework for the medical use of psilocybin, particularly for conditions like post-traumatic stress disorder (PTSD). The bill outlines the establishment of a medical psilocybin program, which includes licensing for psilocybin production establishments, implementing inventory control systems, and requiring background checks for individuals involved in production. It also mandates the creation of a licensing board to oversee operations, emphasizes safety protocols, and ensures that psilocybin treatments are covered by insurance while protecting patients from discrimination based on their use of psilocybin.

Additionally, the bill sets forth comprehensive regulations for psilocybin production, including employment restrictions, facility requirements, and operational protocols. It prohibits the employment of individuals under 21 or those with certain criminal convictions, mandates secure facilities, and outlines inspection rights for compliance checks. The legislation also addresses advertising restrictions, transportation protocols, and waste disposal, while establishing a framework for the registration and continuing education of qualified medical psilocybin providers. Legal protections for providers and patients are included, ensuring that psilocybin use is treated similarly to other prescribed medications, and it clarifies that insurers are not mandated to cover psilocybin treatments.

Statutes affected:
Introduced Version: 16-67-1, 16-67-2, 16-67-3, 16-67-4, 16-67-5, 16-67-6, 16-67-7, 16-67-8, 16-67-9, 16-67-10, 16-67-11, 16-67-12, 16-67-13, 16-67-14, 16-67-15, 16-67-16, 16-67-17, 16-67-18, 16-67-19, 16-67-20, 16-67-21, 16-67-22, 16-67-23, 16-67-24, 16-67-25, 16-67-26, 16-67-27, 16-67-28, 16-67-29, 16-67-30, 16-67-31, 16-67-32, 16-67-33, 16-67-34, 16-67-35, 16-67-36, 16-67-37, 16-67-38